Breast Lymphoma: Favorable Prognosis after Treatment with Standard Combination Chemotherapy

Publisher： Karger

E-ISSN： 2296-5262|29|1-2|14-18

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.1-2, 2006-01, pp. : 14-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dysfunctional neobladder causing pulmonary toxicity after combination chemotherapy for lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : 468-469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch‐and‐wait strategy after complete resection

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 40, Iss. 1-2, 2017-01 ,pp. : 21-26

Karger

Access to resources Recommend Favorite

Successful Treatment of Adult T‐cell Leukemia/Lymphoma with MACOP‐B, M‐FEPA and VEPP‐B Combination Chemotherapy

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 10, 1993-10 ,pp. : 623-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Herceptin® Alone or in Combination with Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Pivotal Trials

By  

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 14-21

Karger

Access to resources Recommend Favorite